Although these therapies are yet to be available for regular use in clinical practice
R2 is required to above 0
with N-terminal 8*His HHHHHHHHGGGGSDYKDDDDKRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNF Expression System HEK293 Molecular Weight 35-43kDa (Reducing) Purity >95% by SDS-PAGE
NF68 Accession P07196 Amino Acid Sequence Protein sequence (P07196
The validity period is 6 months
IGFBP1 Recombinant Rabbit mAb (SDT-196-47) IVD Antigen Recombinant Protein Although these therapies are yetProduct Specification Host Rabbit Antigen IGFBP1 Synonyms Insulin like growth factor binding protein 1, IBP 1; IGF binding protein 1, Placental protein 12, PP12 Immunogen Recombinant Protein Location Secreted Accession P08833 Clone Number SDT 196 47 Antibody Type Recombinant mAb Application WB, ICC, ICFCM Reactivity Hu Purification Protein A Concentration 0. 5 mg ml Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS, 40% Glycerol,